The role of the multidisciplinary team in the decision making process in stage one testicular cancer - retrospective cohort analysis.
To analyze the role of a multidisciplinary team (MDT) in the decision-making process in clinical stage one (CS I) testicular cancer (TC). We retrospectively evaluated data on 115 consecutive patients with CS I TC (excluding stage IS) who were referred to the Department of Oncology, University Hospital of Split, Croatia, from 2003 to 2012. Fifty-six patients (48.7%) were referred between 2003 and 2007, before the introduction of the MDT and 59 patients (51.3%) between 2008 and 2012, after the introduction of the MDT. We evaluated the overall treatment outcome (cure rate) and the total number of patients with CS I TC who were treated or monitored: in seminoma (SA) group adjuvant radiotherapy (ART) vs adjuvant chemotherapy (ACT) or active surveillance (AS) and in non-seminoma (NSA) group retroperitoneal lymphadenectomy (RPLND) vs ACT or AS. After the introduction of the MDT we stopped using ART for CS I SA, and significantly increased the usage of ACT and AS (p<0.001). RPLND in CS I NSA was used significantly less often after the introduction of the MDT while the usage of ACT and AS increased (p=0.047). With the MDT introduction we significantly changed the approach to patients with CS I TC. More aggressive and more toxic forms of the postoperative treatment were replaced by AS or less toxic ACT. Despite less aggressive adjuvant treatment approach, significant changes in the cure rate between two time periods were not noticed.